Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP154755.RApgKXZZxk9Oq6e17H06xlpB3MM-lVcjQuUkfonhN0AMM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP154755.RApgKXZZxk9Oq6e17H06xlpB3MM-lVcjQuUkfonhN0AMM130_assertion type Assertion NP154755.RApgKXZZxk9Oq6e17H06xlpB3MM-lVcjQuUkfonhN0AMM130_head.
- NP154755.RApgKXZZxk9Oq6e17H06xlpB3MM-lVcjQuUkfonhN0AMM130_assertion description "[Mutations in P53 were identified in 25 of 237 tumors (10.5%), which included 1 of 45 small lymphocytic lymphomas (SLLs), 2 of 38 follicular small cleaved-cell lymphomas (FSCCs), 2 of 35 follicular mixed small cleaved-cell and large-cell lymphomas (FMxs), 1 of 4 follicular large-cell lymphomas (FLCs), 1 of 14 diffuse small cleaved-cell lymphomas (DSCCs), 2 of 17 diffuse mixed small- and large-cell lymphomas (DMxs), and 16 of 84 diffuse large-cell lymphomas (DLCCs); the difference between the histologic groups was significant (P < .01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP154755.RApgKXZZxk9Oq6e17H06xlpB3MM-lVcjQuUkfonhN0AMM130_provenance.
- NP154755.RApgKXZZxk9Oq6e17H06xlpB3MM-lVcjQuUkfonhN0AMM130_assertion evidence source_evidence_literature NP154755.RApgKXZZxk9Oq6e17H06xlpB3MM-lVcjQuUkfonhN0AMM130_provenance.
- NP154755.RApgKXZZxk9Oq6e17H06xlpB3MM-lVcjQuUkfonhN0AMM130_assertion SIO_000772 9354678 NP154755.RApgKXZZxk9Oq6e17H06xlpB3MM-lVcjQuUkfonhN0AMM130_provenance.
- NP154755.RApgKXZZxk9Oq6e17H06xlpB3MM-lVcjQuUkfonhN0AMM130_assertion wasDerivedFrom befree-20140225 NP154755.RApgKXZZxk9Oq6e17H06xlpB3MM-lVcjQuUkfonhN0AMM130_provenance.
- NP154755.RApgKXZZxk9Oq6e17H06xlpB3MM-lVcjQuUkfonhN0AMM130_assertion wasGeneratedBy ECO_0000203 NP154755.RApgKXZZxk9Oq6e17H06xlpB3MM-lVcjQuUkfonhN0AMM130_provenance.